# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. The company repo...
NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ:NXGL), a leading provider of medical and over-the-counter (OTC...
The 30-patient study is designed to measure the efficacy of applying NEXGEL's hydrogel during laser hair removal in elimina...
Adam Levy, CEO of NEXGEL, commented, "We are pleased to deliver record revenue for the second quarter of 2024 in spite of l...